UC Nzeako, E Frigas, WJ Tremaine - Archives of Internal Medicine, 2001 - archinte.highwire.org Hereditary angioedema (HAE) is an autosomal dominant disease that afflicts 1 in
10 000 to 1 in 150 000 persons; HAE has been reported in all races, and no sex
predominance has been found. It manifests as recurrent attacks of intense, ... Cited by 117 - Related articles - BL Direct - All 4 versions
M Cicardi, LC Zingale, E Pappalardo, A … - Medicine, 2003 - journals.lww.com Abstract: Angioedema due to acquired C1-inhibitor (C1- INH) deficiency (also
referred to as “acquired angioedema”) is a rare, life-threatening disease
with poorly defined etiology, ther- apy, and prognosis. To define the ... Cited by 50 - Related articles - BL Direct - All 3 versions
L Wen, JP Atkinson, PC Giclas - The Journal of Allergy and Clinical Immunology, 2004 - Elsevier The complement system provides innate defense against microbial pathogens and is
a “complement” to humoral (antibody-mediated) immunity. Consisting of plasma
and membrane proteins, this proinflammatory system works in part by a ... Cited by 48 - Related articles - All 13 versions
D Sondhi, M Lippmann, G Murali - Chest, 2004 - chestjournal.chestpubs.org Results: A total of 70 charts on which a diagnosis of AE had been entered were
reviewed. Of those, 45 patients (64%) had AE that was thought to be related to
ACEI therapy. Of those 45 patients, 29 were women. The mean age was 62 ... Cited by 39 - Related articles - BL Direct - All 9 versions
MD Hill, PA Barber, J Takahashi, AM … - Canadian Medical Association Journal, 2000 - canadianmedicaljournal.ca A major concern of physicians who treat acute ischemic stroke with alteplase, a
recombinant tissue plasminogen activator (rt-PA,) is the risk of intracerebral
hemorrhage. However, other adverse reactions, including anaphylaxis and ... Cited by 38 - Related articles - BL Direct - All 14 versions
- ►bmj.com MM Gompels, RJ Lock, JE Morgan, J Osborne, … - British Medical Journal, 2002 - jcp.bmj.com Results: These are the first data to indicate the sensitivity, specificity, and
predictive values of the assays most frequently used to screen for C1 inhibitor
deficiency. A combination of low C4 and low C1 inhibitor function has 98% ... Cited by 28 - Related articles - BL Direct - All 5 versions
- ►muhealth.org [PDF] M Bas, V Adams, T Suvorava, T Niehues, TK … - Allergy, 2007 - pt.wkhealth.com Angioedema is an underestimated clinical problem. Many cases are nonallergic
reactions, eg bradykinin-induced angioedema caused by genetic defects and
angiotensin-converting enzyme (ACE) inhibitors. This difference is crucial ... Cited by 27 - Related articles - BL Direct - All 8 versions
E Frigas, UC Nzeako - Clinical Reviews in Allergy and Immunology, 2002 - Springer Angioedema is a constellation of syndromes that present a great chal- lenge to
the clinician. The term “angioedema” describes the localized, tran- sient,
episodic edema of the deeper layers of the skin or of the mucosa of the ... Cited by 26 - Related articles - BL Direct - All 5 versions
V Frémeaux-Bacchi, MT Guinnepain, P Cacoub … - The American journal of medicine, 2002 - Elsevier Acquired angioedema type 1 is characterized by a C1 inhibitor deficiency in
patients with lymphoproliferative disorders, whereas acquired angioedema type 2
is characterized by anti-C1 inhibitor antibodies, and has not been thought ... Cited by 25 - Related articles - All 11 versions
BC Ritchie - Transfusion and Apheresis Science, 2003 - Elsevier Deficiency of C1 Inhibitor leads to unopposed activation of complement, with
localized, unpredictable, and sometimes life-threatening attacks of angioedema.
Treatment with plasma-derived C1 Inhibitor rapidly aborts attacks, and may ... Cited by 24 - Related articles - All 9 versions
